Cutler Group’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-4,600
| Closed | -$41K | – | 928 |
|
2023
Q4 | $41K | Buy |
4,600
+3,743
| +437% | +$33.4K | ﹤0.01% | 700 |
|
2023
Q3 | $6K | Sell |
857
-1,296
| -60% | -$9.07K | ﹤0.01% | 1114 |
|
2023
Q2 | $20K | Sell |
2,153
-794
| -27% | -$7.38K | ﹤0.01% | 819 |
|
2023
Q1 | $32K | Sell |
2,947
-1,211
| -29% | -$13.2K | ﹤0.01% | 737 |
|
2022
Q4 | $17K | Buy |
4,158
+900
| +28% | +$3.68K | ﹤0.01% | 1137 |
|
2022
Q3 | $24K | Sell |
3,258
-20,582
| -86% | -$152K | ﹤0.01% | 1128 |
|
2022
Q2 | $239K | Sell |
23,840
-3,573
| -13% | -$35.8K | 0.02% | 419 |
|
2022
Q1 | $339K | Sell |
27,413
-45,779
| -63% | -$566K | 0.02% | 434 |
|
2021
Q4 | $1.67M | Buy |
73,192
+25,559
| +54% | +$584K | 0.07% | 183 |
|
2021
Q3 | $1.05M | Buy |
47,633
+38,433
| +418% | +$850K | 0.05% | 244 |
|
2021
Q2 | $119K | Buy |
9,200
+8,500
| +1,214% | +$110K | 0.01% | 923 |
|
2021
Q1 | $9K | Sell |
700
-4,600
| -87% | -$59.1K | ﹤0.01% | 1638 |
|
2020
Q4 | $73K | Buy |
5,300
+2,400
| +83% | +$33.1K | ﹤0.01% | 879 |
|
2020
Q3 | $42K | Buy |
2,900
+400
| +16% | +$5.79K | ﹤0.01% | 928 |
|
2020
Q2 | $40K | Buy |
+2,500
| New | +$40K | ﹤0.01% | 913 |
|
2020
Q1 | – | Hold |
0
| – | – | – | 1435 |
|
2019
Q4 | – | Sell |
-2,800
| Closed | -$14K | – | 1511 |
|
2019
Q3 | $14K | Sell |
2,800
-2,700
| -49% | -$13.5K | ﹤0.01% | 1123 |
|
2019
Q2 | $36K | Buy |
5,500
+1,400
| +34% | +$9.16K | ﹤0.01% | 1022 |
|
2019
Q1 | $26K | Sell |
4,100
-500
| -11% | -$3.17K | ﹤0.01% | 983 |
|
2018
Q4 | $31K | Buy |
+4,600
| New | +$31K | ﹤0.01% | 967 |
|
2018
Q3 | – | Hold |
0
| – | – | – | 1615 |
|
2018
Q2 | – | Sell |
-600
| Closed | -$3K | – | 1669 |
|
2018
Q1 | $3K | Sell |
600
-1,900
| -76% | -$9.5K | ﹤0.01% | 1610 |
|
2017
Q4 | $11K | Sell |
2,500
-2,800
| -53% | -$12.3K | ﹤0.01% | 1573 |
|
2017
Q3 | $33K | Sell |
5,300
-48,141
| -90% | -$300K | ﹤0.01% | 1446 |
|
2017
Q2 | $327K | Buy |
53,441
+26,001
| +95% | +$159K | 0.01% | 662 |
|
2017
Q1 | $201K | Buy |
27,440
+26,440
| +2,644% | +$194K | 0.01% | 830 |
|
2016
Q4 | $2K | Buy |
+1,000
| New | +$2K | ﹤0.01% | 2641 |
|